403 related articles for article (PubMed ID: 1992461)
1. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.
McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461
[TBL] [Abstract][Full Text] [Related]
2. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.
McMahon EG; Palomo MA; Moore WM
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of biological actions of big endothelin-1 by phosphoramidon.
Fukuroda T; Noguchi K; Tsuchida S; Nishikibe M; Ikemoto F; Okada K; Yano M
Biochem Biophys Res Commun; 1990 Oct; 172(2):390-5. PubMed ID: 2241940
[TBL] [Abstract][Full Text] [Related]
4. Evidence for phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery.
Hisaki K; Matsumura Y; Ikegawa R; Nishiguchi S; Hayashi K; Takaoka M; Morimoto S
Biochem Biophys Res Commun; 1991 Jun; 177(3):1127-32. PubMed ID: 2059203
[TBL] [Abstract][Full Text] [Related]
5. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.
Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006
[TBL] [Abstract][Full Text] [Related]
6. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
7. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
Lebel N; D'Orléans-Juste P; Fournier A; Sirois P
Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361
[TBL] [Abstract][Full Text] [Related]
8. Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells.
Matsumura Y; Tsukahara Y; Kojima T; Murata S; Murakami A; Takada K; Takaoka M; Morimoto S
Biol Pharm Bull; 1995 Mar; 18(3):401-6. PubMed ID: 7550091
[TBL] [Abstract][Full Text] [Related]
9. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
10. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
[TBL] [Abstract][Full Text] [Related]
11. Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells.
Sawamura T; Kasuya Y; Matsushita Y; Suzuki N; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T
Biochem Biophys Res Commun; 1991 Jan; 174(2):779-84. PubMed ID: 1993071
[TBL] [Abstract][Full Text] [Related]
12. Characterization of big endothelin-1-induced contraction in rabbit saphenous artery.
Ferlenga P; Morazzoni G; Da Ros B; Branca E; Fantoni M; Marchini F; Pocchiari F; Semeraro C
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S78-80. PubMed ID: 8587474
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
[TBL] [Abstract][Full Text] [Related]
14. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of a phosphoramidon-sensitive endothelin-converting enzyme in the rat.
Pollock DM; Divish BJ; Milicic I; Novosad EI; Burres NS; Opgenorth TJ
Eur J Pharmacol; 1993 Feb; 231(3):459-64. PubMed ID: 8449237
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
18. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
Emoto N; Yanagisawa M
J Biol Chem; 1995 Jun; 270(25):15262-8. PubMed ID: 7797512
[TBL] [Abstract][Full Text] [Related]
20. Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.
Patel KV; Schrey MP
Br J Cancer; 1995 Mar; 71(3):442-7. PubMed ID: 7880721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
